Fingolimod Hydrochloride CAS 162359-56-0 Tsafta ≥99.0% (HPLC) API Babban Tsabta

Takaitaccen Bayani:

Sunan Sinadari: Fingolimod Hydrochloride

Saukewa: 162359-56-0

Bayyanar: Fari zuwa Kashe-fari foda

Tsafta: ≥99.0% (HPLC)

FDA ta amince da magani don maganin Sclerosis da yawa.

API High Quality, Kasuwancin Kasuwanci

Inquiry: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Mai ƙera tare da Babban Tsafta da Ƙarfin Ƙarfi
Sunan Sinadari: Fingolimod Hydrochloride
Saukewa: 162359-56-0
Fingolimod Hydrochloride magani ne da aka amince da FDA don maganin Sclerosis da yawa.
API High Quality, Kasuwancin Kasuwanci

Abubuwan Sinadarai:

Sunan Sinadari Fingolimod Hydrochloride
Makamantu Fingolimod HCl;Farashin 720
Lambar CAS 162359-56-0
Lambar CAT RF-API39
Matsayin Hannun jari A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram
Tsarin kwayoyin halitta Saukewa: C19H34ClNO2
Nauyin Kwayoyin Halitta 343.93
Matsayin narkewa 102.0 ~ 107.0 ° C
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Kashe-Farin Foda
Ganewa HPLC
Matsayin narkewa 102.0 ~ 106.0 ℃
Solubility Cikakkiyar Narke Cikin Ruwa
Tsarkake / Hanyar Bincike ≥99.0% (HPLC)
Danshi (KF) ≤0.50%
Ragowa akan Ignition ≤0.20%
Karfe masu nauyi ≤20ppm
Ragowar Magani
Dichloromethane ≤0.05%
Ethyl acetate ≤0.50%
Ethanol ≤0.50%
Methanol ≤0.30%
Toluene ≤0.089%
THF ≤0.50%
DMF ≤0.088%
Abubuwan Dangantaka
Tsaftace Guda Daya ≤0.50%
Jimlar ƙazanta ≤1.0%
Matsayin Gwaji Matsayin Kasuwanci
Amfani Sinadarin Magunguna Mai Aiki (API)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.

Amfani:

1

FAQ:

Aikace-aikace:

Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai samar da Fingolimod Hydrochloride (CAS: 162359-56-0) tare da inganci mai inganci.
Fingolimod Hydrochloride shine maganin baka na farko don maganin sclerosis da yawa.Kamfanin samar da magunguna Novartis ya samu nasarar haɓaka shi, kuma Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da ita don tallatawa.Multiple sclerosis cuta ce mai lalacewa wanda zai iya sa mai haƙuri ya rasa ma'anar ma'auni, bayyanar ƙwayar tsoka da sauran cututtuka na motsi.Fingolimod Hydrochloride shine sphingosine-l-phosphate (S1PR).Bayan phosphorylation, Yana daure zuwa s1P mai karɓa wanda ke kan saman lymphocyte, wanda zai canza ƙaura na lymphocyte, kuma ya inganta sel a cikin ƙwayar lymph, kuma ya hana lymphocytes daga barin ƙwayar lymph kuma shiga cikin dasa.Ta haka, zai hana waɗannan ƙwayoyin cuta shiga cikin tsarin juyayi na tsakiya (CNS), wanda ke samun tasirin rigakafin rigakafi.

Ku rubuta sakonku anan ku aiko mana